Claritin-D ® 12 Hour

Claritin-D by

Drug Labeling and Warnings

Claritin-D by is a Otc medication manufactured, distributed, or labeled by REMEDYREPACK INC.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

CLARITIN-D 12 HOUR- loratadine and pseudoephedrine sulfate tablet, extended release 
REMEDYREPACK INC.

----------

Claritin-D ®



12 Hour

Drug Facts

Active ingredient (in each tablet)Purpose
Loratadine 5 mgAntihistamine
Pseudoephedrine sulfate 120 mgNasal decongestant

Uses

  • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
    • sneezing
    • itchy, watery eyes
    • runny nose
    • itching of the nose or throat
  • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
  • reduces swelling of nasal passages
  • temporarily relieves sinus congestion and pressure
  • temporarily restores freer breathing through the nose

Warnings

Do not use

  • if you have ever had an allergic reaction to this product or any of its ingredients
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  • heart disease
  • thyroid disease
  • high blood pressure
  • diabetes
  • trouble urinating due to an enlarged prostate gland
  • liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed.

Taking more than directed may cause drowsiness.

Stop use and ask a doctor if

  • an allergic reaction to this product occurs. Seek medical help right away.
  • symptoms do not improve within 7 days or are accompanied by a fever
  • nervousness, dizziness or sleeplessness occurs

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • do not divide, crush, chew or dissolve the tablet
adults and children 12 years and over1 tablet every 12 hours; not more than 2 tablets in 24 hours
children under 12 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information

  • each tablet contains: calcium 30 mg
  • safety sealed: do not use if the individual blister unit imprinted with Claritin-D ® 12 Hour is open or torn
  • store between 20° to 25°C (68° to 77°F)
  • keep in a dry place

Inactive ingredients

croscarmellose sodium, dibasic calcium phosphate, hypromellose, lactose monohydrate, magnesium sterarate, pharmaceutical ink, povidone, titanium dioxide

Questions or comments?

1-800-CLARITIN (1-800-252-7484) or www.claritin.com

DRUG: Claritin-D12 Hour 12 Hour

GENERIC: Loratadine and pseudoephedrine sulfate

DOSAGE: TABLET, EXTENDED RELEASE

ADMINSTRATION: ORAL

NDC: 70518-3566-0

COLOR: white

SHAPE: OVAL

SCORE: No score

SIZE: 12 mm

IMPRINT: Claritin;D;12

PACKAGING: 10 in 1 BLISTER PACK

OUTER PACKAGING: 2 in 1 CARTON

ACTIVE INGREDIENT(S):

  • PSEUDOEPHEDRINE SULFATE 120mg in 1
  • LORATADINE 5mg in 1

INACTIVE INGREDIENT(S):

  • CROSCARMELLOSE SODIUM
  • CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
  • HYPROMELLOSES
  • LACTOSE MONOHYDRATE
  • MAGNESIUM STEARATE
  • POVIDONE
  • TITANIUM DIOXIDE

Remedy_Label

CLARITIN-D  12 HOUR
loratadine and pseudoephedrine sulfate tablet, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 70518-3566(NDC: 11523-7162)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE5 mg
PSEUDOEPHEDRINE SULFATE (UNII: Y9DL7QPE6B) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE SULFATE120 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
POVIDONE (UNII: FZ989GH94E)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
Colorwhite (white to off-white) Scoreno score
ShapeOVALSize12mm
FlavorImprint Code Claritin;D;12
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 70518-3566-02 in 1 CARTON10/31/202211/03/2023
110 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA01967010/31/202211/03/2023
Labeler - REMEDYREPACK INC. (829572556)

Revised: 10/2024
 

Trademark Results [Claritin-D]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CLARITIN-D
CLARITIN-D
76506212 2819388 Live/Registered
BAYER HEALTHCARE LLC
2003-04-14
CLARITIN-D
CLARITIN-D
74659413 1960278 Dead/Cancelled
Schering Corporation
1995-04-05
CLARITIN-D
CLARITIN-D
74475937 1912214 Live/Registered
BAYER HEALTHCARE LLC
1994-01-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.